INHIBITION OF THEILER'S ENCEPHALOMYELITIS VIRUS (GDVII STRAIN) OF MICE BY AN INTESTINAL MUCOPOLYSACCHARIDE : II. PURIFICATION AND PROPERTIES OF THE MUCOPOLYSACCHARIDE by Mandel, Benjamin & Racker, Efraim
INHIBITION  OF  THEILER'S  ENCEPHALOMYELITIS  VIRUS 
(GDVII  STRAIN)  OF  MICE  BY  AN  INTESTINAL 
MUCOPOL¥SACCHARIDE 
II. PURIFICATION  AND PROPERTIES  OF I'~I~  MUCOPOLYSACCHAEIDE* 
BY BENJAMIN  MANDEL,:~  I~.D., AND EFRAIM RACKER,§ M.D. 
(From the  Department of Microbiology, New  York  University  College of Medicine, 
New York) 
(Received for publication, June 25, 1953) 
In the preceding paper (1) it was shown  that the intestinal tissue  of  adult 
mice contains a  substance capable of inhibiting the GDVII strain of  Theiler's 
encephalomyelitis virus of mice. The inhibitor was demonstrated to  be active 
against the hemagglutinating, as well as the pathogenic activities of  the  virus. 
Evidence was presented which showed  that  the inhibitor is highly specific in 
its action, and that it functions by combining with the virus. 
In the present paper the method  of purification of the inhibitor will be de- 
scribed. The results of studies of some of the physicochemical properties which 
indicate that the inhibitor is a  mucopolysaccharide will be presented. 
Materials and Methods 
Acetone-Dried Pouder.--The preparation of an acetone-dried  powder from tissue and the 
methods for measuring inhibitory activity are described in the preceding paper (i). 
Chromatographic Analyses.--The identification  of amino adds was carried out following the 
method of Consden, Gordon, and Martin (2). Two dimensional analysis was carried out using 
Whatman 1 paper with water-saturated s-coUidine  and water-saturated phenol as the solvents. 
With the latter solvent, the aqueous phase in the tank contained 3 per cent NHs and a trace 
of KCN was added as described (2). A tank was constructed following the directions of Toen- 
hies and Kolb (3). The spraying reagent was a 0.1 per cent solution of ninhydrin in butanol 
containing  1 per cent acetic acid (4). 
EXPE~NTAL 
Purification of the GDVII Virus  Inh'~itor.--A large pool of acetone-dried powders of mouse 
intestine was extracted with 10 volumes of distilled  water at 37°C. for 1 hour. After centrifuga- 
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tion  at 2500 ~.e.~.  for  30 minutes, the supemate was decanted and saved.  The sediment  was 
washed once  with  a small  volume of  water,  the  washings  combined  with  the  supernate,  and the 
sediment discarded.  Advantage was taken of the fact  that this  crude extract  contains  phos- 
phatase.  Magnesium chloride  was added to  a concentration  of  0.005 M, the pH adjusted to 8, 
and the  extract  was  incubated at  37°C. At the  start  of  incubation  the  total  phosphorus  content 
was determined  on a sample. After  2 to  3 hours'  incubation nearly  all  the organic  phosphorus 
was liberated  as  inorganic  phosphorus. 
To each  liter  of  solution,  250 ml. of  25 per  cent  trichloracetic  acid  was  added. After  centrif- 
ugation at  2500  x.p.x~,  for  30 minutes, the supernatant solution  was decanted  and saved.  The 
sediment  was washed with a small volume of 5 per cent trlchloracetic  acid and the washings 
were added to  the supernatant solution  which was then dialyzed  against  distilled  water  in  the 
cold for 24 hours with several  changes of  water. During dialysis  a fine  precipitate  which de- 
veloped was removed by centrifugation.  In order to remove any residual  protein from this 
solution,  200 ml. of chloroform and 40 ml. of ~butanol were added to each liter  and the 
mixture shaken vigorously for 30 minutes in a shaking machine. After centrifugation,  the 
TABLE I 
Puriflcaaon of the GDVII Virus Inhibilor from Intestinal  Tissue of Adult Mica 
Fraction 
Acetone-dried powder 
rCAt superuate (dialyzed) 
~dter chloroform treatment 
Mcohol precipitate 
CuSO~ supemate (dialyzed) 
Final 
Weight 
144.0 
1.507 
0.2OO3 
Volume of 
extract 
ml. 
1410 
1970 
1960 
24.7 
42.0 
Total 
HIU* 
m//l/~n 
38.5 
25.8 
26.7 
15.8 
7.2 
6.2 
;pecific 
mtivity 
~ ~IU/rr,  J. 
0.27 
11.2 
31.0 
giel, 
70 
70 
44 
19 
16 
Purificatim 
41 
115 
* Hemagglutination-inhibition units. 
Trichloracotic acid. 
upper aqueous phase was siphoned off, fresh chloroform and butanol added  to it, and the 
shaldng was repeated. After 3 or 4 cycles,  a precipitate no longer formed at the interface. 
To each liter of the deproteinized solution, 100 gin. of sodium acetate (NaC2HsOv3HsO) 
was added. The polysaccharide was then precipitated by adding 3 volumes of 95  per cent 
ethanol and allowing the n~ture to stand in the cold overnight. The precipitate was collected 
by centrifugation, washed successively with small volumes of absolute ethanol and ether, and 
dried Sn racuo. The inhibitor was extracted from this powder with distilled water. Residual 
nucleic acid was removed from this extract by adding 1 volume of 10 per cent CuSO4.5I-I20 
to each 5 volumes of solution and adjusting the pH to 5.1. The resulting precipitate was re- 
moved by centrifugation, washed with a  small volume of 2 per cent CuSO4.51~O,  and dis- 
carded. The combined supematant solutions were dialyzed against several changes of 0.01 N 
HC1 for 24 hours and then against several changes of distilled water for 24 hours. After dialysis 
the solution was lyophlHzed. 
In order to determine purification and yield, allquots were collected at each step and inhibi- 
tory activity was measured by hemagglutination inhibition. 
A  protocol for one preparation  is shown  in  Table  I.  Specific activity is ex- 
pressed  as hemagglutination-inhibition  units  per gram of dry weight.  The ac- BENJAMIN MANDEL  AND EFRAIM RACKER  419 
tivity was determined on an extract of the dry powder in the case of the acetone 
powder  and  the  alcohol  precipitate.  The  final  lyophilized  material  is  com- 
pletely soluble.  The  data  in  Table I  show  that  a  lI5-fold purification  was 
achieved with a yield of 16 per cent. 
The purification method of Morgan and King (5), which has proved to be 
highly effective with the blood group substances, was tried for the purification 
of the GDVII virus inhibitor. Although a relatively pure product was obtained, 
the yield was only about I0 per cent of the amount obtained by the above de- 
scribed procedure. 
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Fro. 1. Ultraviolet absorption spectrum of the inhibitor (1.0 mg./nd,  in distilled water) 
measured in a 1 cm. cell with a Beckman model DU spectrophotometer. 
Physical Properties.--A  1 per cent solution of the inhibitor in water is dear 
with a  barely perceptible brownish color. The inhibitor in neutral solution is 
stable to prolonged storage in the frozen state, and may be heated for 10 min- 
utes at 115°C.  without adverse effect. When a  sample of the dry powder was 
heated at 100-105°C. for 3 days in an oven, the activity was reduced to 25 per 
cent of its original value. 
The viscosity of a  1 per cent solution in distilled water was determined in an 
Ostwald viscosimeter at 37°C. and was found to be 2.31,  relative to water. 
The absorption spectrum of a  0.1  per cent solution, determined in a  1 era. 
cell in a Beckman spectrophotometer, is shown in Fig. 1. 
Water Content.--The  water content of the powder obtained after lyophiliza- 
tion was determined by heating a  sample at  100--105°C.  to constant weight; 
it was found to contain 15 per cent water. All subsequent analytical data will 
be reported as corrected values. 
Phosphorus and Nitrogen.--The total phosphorus content was found  (6)  to 
be 0.08 per cent. The maximum amount of nucleic acid that could be present 
therefore is about 1 per cent.  The nitrogen  content was found to be 5.9 per 
cent by direct nesslerization as described by Koch and MeMeekin (7). 420  INHIBITION  O~  THEILER'S  VIRUS  (GDVII),  II 
Carbohydrate Components.--The rate of appearance of reducing sugars and 
hexosamine was determined by heating  1 nag.  samples of the inhibitor with 
0.5 N HCt at 100°C. After varying periods of time the tubes were removed and 
opened. 90 per cent of the amount of sodium hydroxide required to just neu- 
tralize  the  hydrolysis mixture  was  added  cautiously.  Aliquots  of  each  hy- 
drolyzed sample were used for the determination of reducing sugars  (8)  and 
hexosamine (9). The results are depicted graphically in Fig. 2. 
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FIG. 2. Hydrolysis of inhibitor in 0.5 z~ HC1 at 100°C. with liberation of reducing sugars 
(as glucose) and hexosamine (as glucosamine). 
As shown in Fig. 2,  the 2 curves reached a  maximum at about 3 hours at 
which time 53.4 per cent of the original dry weight was present as reducing 
sugars and 31.8 per cent as hexosamine. An analysis of the unhydrolyzed in- 
hibitor showed 3.7  and 6.5  per cent reducing sugars and hexosamine respec- 
tively. 
N-Acetylhexosamine and  methylpentose were  determined  by  hydrolyzing 
1 mg. samples of inhibitor in 2 z~ acetic acid at  100°C.  in sealed tubes. After 
various periods of heating, the tubes were opened and the contents evaporated 
to dryness in a  vacuum desiccator containing sulfuric acid and potassium hy- 
droxide. The residues were redissolved and each hydrolysate was analyzed for BENJAMIN MANDEL  AND EFRAIM RACKER  421 
N-acetylhexosamine (10), methylpentose (11), reducing sugars, and inhibitory 
activity. 
As shown in Fig. 3, N-acetylhexosamine reached a maximum of 20 per cent 
after 7 hours.  A  control  (N-acetylglucosamine) treated as above showed no 
decrease after 7 hours, but after 24 hours only 90 per cent of the theoretical 
amount was recovered. Total reducing sugar content had not reached a maxi- 
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Fie. 3. Hydrolysis of inhibitor  in 2 N acetic acid at 100°C.  with liberation  of reducing sugars 
(as gluco~), N-acetylhexommine  (as N-acetylglucos~mlne),  and methylpentose (as fucose). 
Destruction of biological activity is shown by the decrease in hemagglutination inhibition 
units (logarithmic  scale) with time of hydrolysis. 
mum even after 24 hours whereas methylpentose showed no increase over the 
value  obtained for  the  unhydrolyzed material  which  was  2.7  per  cent.  In- 
hibitory activity diminished rapidly, about 10 per cent remaining after the 1st 
hour of heating. 
By means of the cysteine reaction (SCyRI) described by Dische et al.  (12), 
the presence of galactose was demonstrated. An analysis for hexuronic acid by 
the carbazole reaction (13) revealed that 8.3 per cent, as glucuronic acid, was 
present. 
When total carbohydrate content was determined by a  modification of the 422  mmsi~mN or  Tm~rL~X'S virus  (oDv=).  n 
anthrone reaction (14), the value obtained was 21.9 per cent as glucose, which 
is considerably lower than the value of 53.4 per cent obtained by determining 
the reducing sugars on a  hydrolyzed specimen. An investigation of the speci- 
ficity of the anthrone reaction showed that neither hexosamine nor hexuronic 
acid reacted with anthrone to produce the characteristic color. When the values 
of these 2 carbohydrates are added to that obtained with the anthrone reagent, 
there is an approximate agreement with the result obtained for reducing sugars 
after hydrolysis. 
Amino Acid Components.--The  "protein" content of the inhibitor was found 
to be 17.5 per cent by the method of Lowry et a/.,  (15) with a purified casein 
standard.  A  spectrophotometric assay  (16)  showed  11.2  per cent  "protein." 
In view of the  drastic  deproteinizing measures employed in  the purification 
procedure, it seems unlikely that any native protein as such is present. Further- 
more,  since  both  methods  are  actually  based  upon  the  presence  of  certain 
amino acids, it seems preferable at present to view the above results as indicat- 
ing the presence of peptides or amino acids combined with the polysaccharide. 
On this basis the inhibitor has been considered to be a  mucopolysaccharide. 
The identification of the individual amino acids by partition chromatography 
was undertaken. 
A sample of the inhibitor was hydrolyzed for 18 hours with 6 N HCI at ll0°C, in a sealed 
glass tube. The hydrolysate had become  dark amber in color and contained a black precipitate. 
The precipitate was removed by centrifugation and washed. The washings and supernatant 
fluid were combined and evaporated to dryness in va~uo. The residue was dissolved in a small 
volume of water and analyzed for amino acids by two dimensional chromatography. 
The hydrolysate of the  inhibitor  was resolved into  7  spots.  One,  with  an 
R! of 0.08 in phenol, could not be identified. The remaining spots corresponded 
in  their positions  to  those  of aspartic acid,  glutamic acid,  serine,  threonine, 
alanine, and isoleucine. 
Periodate Oxidation.--It  has been shown  that  the  receptor substances  for 
the influenza-mumps-Newcastle disease virus group are inactivated by perio- 
date  (17).  Similarly,  the  mucopolysaccharide  blood  group  substances  have 
been shown (18) to be oxidized by periodate. The stability of the GDVII virus 
inhibitor towards this reagent was investigated. 
To 0.3 ml. of an inhibitor solution (1 mg./ml.), 0.15 ml. of 0.1 ~s lithium periodate was 
added and the mixture was held for 23 hours at room temperature. The reaction was stopped 
by adding 0.05 hal. of 50 per cent glucose. As a control, the periodate and glucose were mixed 
3 hours prior to the addition of the inhibitor. The mixture was then held for 23 hours at room 
temperature. Each mixture was assayed for inhibitory activity in ~vo and/n dtro. As shown 
in Table II, destruction of the inhibitor by periodate was almost complete. 
Homogeneily of the Purified Inhibitor.--From the preceding data it is clear 
that the most highly purified inhibitor preparation contains carbohydrate and BENJ'.4MTN MANDEL AND EFRAIM RACKER  423 
amino  acid  components.  Since  data  are  not  available  regarding  the  homo- 
geneity of the preparation, the question arises regarding the nature of the bio- 
logically active material. The possibilities to be considered are (a)  either the 
carbohydrate or  the  amino  acid component  is  the  active substance;  (b)  the 
biological activity is associated with both components; (c) the active substance 
is present as a  third component. This problem was approached by attempting 
to  separate  the  above  components  by  partition  chromatography  and  deter- 
mining biological activity. 
TABLE II 
E~ec~ of Lithium Periodat~ on the Activity of the GDVII Virus Inhibitor 
S~c~en 
ntfibitor -{- periodate 
.'ontrol 
Hema~qlutination 
inhibition 
HIUIral. 
100 
3,200 
Infectivity 
inhibition* 
1 
0.24 
0.03 
Virus control 
! 
T 
0.26 
* Each specimen was diluted 1:4 before it was mixed with an equal volume of the virus 
suspension;  consequently there were  12.5 and 400 HIU per ml. respectively in the inocula. 
Six sheets of Whatman I paper, 40 by 4 cm. were washed with the solvent to be used. When 
dry, each sheet was marked off at the edges at 1 cm. intervals. On each of three of the sheets 
a solution containing 2 mg. of inhibitor was placed 4.5 cra. from the lower edge. The remaining 
3 sheets served as controls. Each pair of sheets was suspended in a chromatography chamber 
with about 1 cm. of the lower edge immersed in the developing solvent. The following solvents 
were employed: (a) 0.1 M phosphate buffer, pH 7.3; (b) 55 per cent ethanol; (¢) 60 per cent 
ethanol. When the solvents had ascended approximately 30 cm., the sheets were removed, 
dried at room temperature, and cut into 1 cm. strips. Each strip was placed in a test tube 
containing 1.5 nil. water, the tubes were heated for 1 hour at 60°C. and the paper strips were 
removed.  The eluates were  centrifuged  and the supernatant fluids were pipetted off, care 
being taken to avoid carrying over any paper fibers. Each eluate was analyzed for (a) carbo- 
hydrate by the SCyRI reaction of Dische (12) using galactose as a  standard; (b) "protein" 
by the method of Lowry e~ a/. (15) with a purified casein standard; (¢)  inhibitory activity by 
the hemaggintination-inhibition method.  The values obtained  for the control sheets  were 
used as blank values and the experimental results were corrected accordingly. 
The results of these experiments are shown in Figs. 4 to 6. It can be seen that 
the inhibitor migrated most  rapidly when  the  solvent was  phosphate  buffer 
(Fig. 4), and least rapidly with the 60 per cent ethanol solvent (Fig. 6). Each 
attempt to separate the carbohydrate and "protein" components by the use of 
a  different solvent was unsuccessful, and in each case there is an approximate 
parallelism between  the  2  components  and  biological activity. The  inability 
to separate the 2  components from each other or from the biologically active 
substance strongly indicates that the carbohydrate and "protein" are combined 
and  that  this  complex  possesses  the  inhibitory  activity.  With  the  ethanol 424  mm~rrioN  oF  zm~z~R's  vn~us  (aDvn).  rl 
30  ~0 
~25  -~  50 
:  0 
E  ~ 
z20  - ~40 
,'5,  < 
o  15  -  ~$O 
~k  ,,, 
z  I0  -  <20 
uJ  ¢3 
I-  >- 
o  -~  I0  n-  5 
(1.  rn 
n., 
0  o  0 
0 
SOLVENT : 
PHOSPHATE  BUFFER 
0.1  M  pH  7.:5 
•  Inhibitory  Activity 
¢  Protein 
o  Carbohydrate 
I  I  I  I  l  l 
8  12  16  20  24.  28  32 
DISTANCE  MIGRATED  ON  PAPER  (cm.) 
FI(;. 4 
6,000 
5,000 
4,000 i 
3,000 
2,000 
I, 000  7., 
-i- 
Z 
I 
0 
36 
30  "  60 
25"  ,,,50 
03 
20  -  ~40 
Z  _j 
LU  '~ 
15-  ~30 
o  ::L 
::L  "' 
I0-  ,~20 
z  n- 
-  Q 
I- 
0  5"  T  I0 
n-  0  0.  n~ 
n- 
O"  o  O 
SOLVENT:  55%  ETHANOL 
elnhibltory  Activity 
wProtein 
oCarbohydrate 
4  B  12  16  20  24  28 
DISTANCE  MIGRATED  ON  PAPER  (cm.) 
FzG. 5 
6,000 
"3. 
5,000 .~ 
'I" 
4,000 
I- 
3,000 _~ 
I- 
0 
2,000 ~. 
n- 
O 
1.1. 
1,000 
Z 
0 
FIGs. 4, 5, and 6. Partition chromatography of inhibitor on paper and analysis of eluates 
of different levels of the paper for inhibitory activity, carbohydrate, and "protein." Solvents 
used were phosphate buffer  (Fig. 4),  55 per cent ethanol (Fig. 5),  and 60 per cent ethanol 
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solvents (Figs. 5 and 6)  there are suggestions of minor "protein" impurities 
which are devoid of biological activity. 
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DISCUSSION 
At present the data are too meager to permit any speculation as to the rela- 
tionship of the chemical nature of the inhibitor to its mode of action. What 
is perhaps of interest is that this inhibitor is similar in the gross to other bio- 
logically active polysaccharide-protein complexes such as the urinary (19) and 
egg white (20) hemagglutination-inhibitors, a  bacteriophage inhibitor derived 
from Phase II Shigella sonnel (21), and the blood group substances (5, 18, 22). 
That the inhibitor is not a murine blood group substance is shown by the ob- 
servation that the blood of mice is devoid of inhibitory activity. 
SUMMARY 
A mucopolysaccharide inhibitor of TheileFs  GDVII virus has been purified 
from intestinal tissue of adult mice. The  purified material has been shown to 
consist  chiefly of  carbohydrate. Following acid  hydrolysis of  the  inhibitor, 
several amino acids were found  to be present. The carbohydrate components 
shown to be present thus far are galactose, hexosamine, N-acetylhexosamine, 426  INHIBITION OF TIt'EILER'S VIRUS (GDVII). II 
methylpentose, hexuronic acid; an  indication has  been  obtained  that  sedo- 
heptulose is also present.  The available evidence strongly suggests that  this 
mucopolysaccharide, and not some other substance present in minute amounts, 
is the inhibitor of the GDVII virus. 
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